GB2141123A - Phosphorus substituted acetic acid derivatives - Google Patents

Phosphorus substituted acetic acid derivatives Download PDF

Info

Publication number
GB2141123A
GB2141123A GB08412637A GB8412637A GB2141123A GB 2141123 A GB2141123 A GB 2141123A GB 08412637 A GB08412637 A GB 08412637A GB 8412637 A GB8412637 A GB 8412637A GB 2141123 A GB2141123 A GB 2141123A
Authority
GB
United Kingdom
Prior art keywords
stand
substituted
general formula
compound
stands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08412637A
Other versions
GB8412637D0 (en
Inventor
Dr Csaba Jaszberenyi
Dr Rezso Bognar
Ilona Petrikovits
Dr Ferenc Joo
Erika Trocsanyi
Dr Vilmos Simonidesz
Dr Magda Huhn
Julia Remport
Dr Gabor Kovacs
Dr Gabor Kulcsar
Lukrecia Benesch
Katalin Marmarosi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of GB8412637D0 publication Critical patent/GB8412637D0/en
Publication of GB2141123A publication Critical patent/GB2141123A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/53Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5304Acyclic saturated phosphine oxides or thioxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)

Abstract

Phosphorus containing acetic acid derivatives have the general formula (I> <IMAGE> wherein R<3> and R<4> are the same or different and represent hydrogen, halogen, hydroxy, amino, sulphonic acid group or a specified organic group or R<3> and R<4> together represent oxo-, hydroxyimino, O-alkylimino or substituted alkylhydroxyimino, R<5> represents phenyl, substituted phenyl, 1-methyl-tetrazol-5-yl, 2-methyl-1,3,4-thiadiazol-5-yl, 1,3,4-thiadazol-2-yl, 1,2,3-triazol-4-yl, 1-substituted-tetrazol-5-yl, pyrrolidin-2,5-dion-1-yl, sacharyl, 1- phenyl-3-methyl-pyrazol-4-in-5yl, 8-quinolyl or substituted 8-quinolyl or Q<4>R<5> can optionally represent halogen and R<5> can further represent N,N'-optionally substituted amidine in which the carbon atom of the amidine group is attached to Q<4> atom, and R<5> can further represent alkoxycarbonyl, aryloxycarbonyl or aralkyloxycarbonyl, R<6> and R<7> are the same or different and represent hydrogen, an optionally substituted straight or branched chained C1-6 alkyl group C3-6 cycloalkyl, phenyl or an optionally substituted phenyl group Q<1>, Q<2> and Q<3> are the same or different and typically represent O or S, Q<4> stands for O or S, k, m and n individually represent 0 or 1. The compounds of the general formula (I) can be used for the preparation of phosphorus-containing penicillanic/cephalosporin derivatives as acylating agent. Some of the compounds of the general formula (I) have potential use as antibacterial, antiviral, antifungal and herbicidal agents.

Description

SPECIFICATION Phosphorous substituted acetic acid derivatives and process for the preparation thereof The present invention is directed to new phosphorous substituted acetic acid derivatives of the general formula I
and process for the preparation thereof.
In the general formula the substituents are defined as follows: R3 and R4 are the same or different and can stand for hydrogen, halogen, alkyl, optionally substituted aryl, hydroxy, amino, ,substituted carbonyl amino, acylamino, mono- or dialkylamino, carboxyl, esterified carboxylic acid or sulphonic acid group or a heteroaromatic group or R3 and R4 together stand for oxohydroxyimino, O-alkylimino or substituted alkylhydroxyimino, R5 stands for phenyl, substituted phenyl, such as trichlorophenyl, pentachlorophenyl, pentafluorophenyl, 1-methyl-tetrazol-5-yl, 2-methyl-l ,3,4-thiadiazol-5-yl, 1-, 3,4-thiadiazol-2-yl, 1,2,3-triazol-4-yl, 1 -substituted-tetrazol-5-yl, pyrrolidin-2, 5-dion- 1 -yI, sacharyl, 1 -phenyl-3-methyl-pyrazol- 4-in-5-yl, 8-quinolyl or substituted 8-quinolyl or Q4R5 can optionally stand for halogen and R5 can further stand for N,N'-optionally substituted amidine in which the carbon atom of the amidine group is attached to Q4 atom, and R5 can further stand for alkoxycarbonyl, aryloxycarbonyl or aralkyloxycarbonyl, R6 and R7 are the same or different and can stand for hydrogen, straight or branched chained C16 alkyl which can optionally be substituted by one or more nitro groups, halogen atoms, alkoxycarbonyl or dialkylamino groups and R6 and R7 further stand for C36 cycloalkyl, phenyl or a phenyl group optionally substituted by R1 or R2 where R1 and R2 are the same or different and can stand for hydrogen, halogen, alkyl, hydroxy, nitro, sulphonic acid, carboxylic or NR9R'0 group, wherein R9 and R'O are the same or different and can stand for C16 alkyl or C37 cycloalkyl or R9 and R10 together with the nitrogen atom can form a C37 heterocyclic ring which can optionally contain other heteroatoms or R6 and R7 can optionally be bound to an unsubstituted or substituted atom group forming thus a ring or rings, Q' and Q2 are the same or different and can stand for 0, S or Se or = CH2 group, Q3 can stand for 0, S, Se, = NH, = NR11 or = N-N = CR'2R'3, Q4 stands for 0 or S, R11, R12 and R13 stand for C, 6 alkyl, C37 cycloalkyl, phenyl or substituted phenyl, naphthyl or substituted naphthyl or a cyclic substituent containing one or more hetero atoms which can be substituted or unsubstituted or optionally heteroaromatic, k stands for 0 or 1, m stands for 0 or 1, and n stands for 0 or 1.
The compounds of the general formula I can be used as acylating agents for the preparation of the new biologically active semisynthetic penicillanic acid derivatives of the general formula X
disclosed in the Hungarian patent application No. 1713/83 and of the semisynthetic cefalosporanic acid derivatives of the general formula Xl
disclosed in Hungarian patent application No. 1714/83.
In the general formulae X and Xl R3, R4, R6, R9, R10, Q1, Q2, Q3, k, m and n are as defined above and R15 and R16 are the same or different and can stand for hydrogen, C16 alkyl, C37 cycloalkyl or optionally substituted phenyl, or R15 and R16 can form a heterocyclic ring with the carbon atom to which they are attached, R8 stands for hydrogen or methoxy, Q5 stands for hydrogen, halogen, methyl, acetoxymethyl, acyloxymethyl, methoxy, pyridiniummethyl or Het-S-methyl-wherein Het stands for a 5- or 6-membered monocyclic or a bi- or tricyclic heteroaryl group containing one or more nitrogen and/or other hetero atoms, Y stands for carboxyl, acetoxy, methoxycarbonyl, methoxy-methoxycarbonyl, pivaloyloxymethoxycarbonyl, optionally substituted tetrazol-5-yl and w stands for 0, 1 or 2 and p is O or 1.
Some representatives of the compounds of the general formula I are valuable antibacterial, antiviral, anti-fungal and herbicidal agents per se.
The compounds of the general formula i can be prepared by a) reacting a compound of the general formula Il
wherein R3, R4, R6, R7, Q1, Q2, Q3, n, m and k are as given above and R stands for hydrogen, metal atom, C16 alkyl or C36 cycloalkyl-with a compound of the general formula H04R5, (Ill) Q4 stands for 0 or S, R5 stands for phenyl, substituted phenyl, such as trichlorophenyl, pentachlorophenyl, pentafluorophenyl, 1 -methyl-tetrazol-5-yl, 2-methyl- 1,3, 4-thiadiazol-5-yl,, 1 , 3 ,4-th iadiazol-2-yl, 1,2,3-triazol-4-yl, 1 -substituted-tetrnzol-5-yl, pyrrol idin-2, 5-dion- 1 -yl, sacharyl, 1 -phenyl-3-methyl-pyrazol4-in-5-yl, 8-quinolyl or substituted 8-quinolyl group or N,N'-optionally substituted amidine wherein the carbon atom of the amidine group is attched to Q4 atomor b) reacting the compound of the general formula (llFwherein the substituents are as given abovc -with a halogenating agent in order to prepare compounds of the general formula (I) containing halogen in place of Q4R5 or c) reacting a compound of the general formula (sl)--wherein the substituents are as given above with a compound of the general formula (IV) X-COOR'4 (IV) wherein X stands for halogen and R14 stands for alkoxycarbonyl, aryloxycarbonyl or aralkyloxycarbonyl-in order to prepare a compound of the general formula (I) which contains alkoxycarbonyl, aryloxycarbonyl or arnlkyloxycarbonyl in place of R5, or (d) oxidizing a compound of the general formula (V)
wherein R3, R4, R5, , R7 and Q4 are as given above--in order to prepare a compound of the general formula (lfwherein k and n stands for 0, m stands for 1, Q3 represents oxygen and R3, R4, R5, R6, R7 and Q4 are as given above or e) reacting a compound of the general formula (V) with sulfur in order to prepare a compound of the general formula (lWwherein k and m stand for 0, n stand for 1, Q3 is sulfur and R3, R4, R5, R6, R7, and Q4 are as defined above -----, or f) reacting a compound of the general formula (VI)
- wherein R3, R4, R5, R6, R7 and Q4 are as defined above with P4S,o in order to prepare a compound of the general formula (li wherein k and m stand for 0, n stands for 1, Ql is sulfur and R3, R4, R5, R6, R7 and Q4 are as defined above or g) reducing a compound of the general formula (VI)-wherein R3, R4, R5, R6, R7 and Q4 are as defined aboveselectively with phenyl silane, in order to prepare a compound of the general formula (lWwherein k, m and n stand for 0, R3, R4, R5, R6, R7 and Q4 are as given above, or h) desulfurating a compound of the general formula (VII)
wherein R3, R4, R5, R6, R7 and 04 are as given above, in order to prepare a compound of the general formula (lHwherein K, m and n stand for 0, R3, R4, R5, R6, R7 and Q4 are as given above, or i) reacting a compound of the general formula (VIII) R6R7PM (VIII) wherein R6 and R7 are as given above and M stands for hydrogen or a metal atom-with a compound of the general formula (IX)
wherein Hlg stands for halogen, s stands for 0 or 1 and R3, R4, R5 and Q4 are as given above, in order to prepare a compound of the general formula (lWwherein m, k and n stand for O R3, R4, R5, R6, R7 and Q4 are as given above.
The reaction of the compounds of the general formulae (II) and (III) according to variant a) is preferably performed in an inert solvent which does not change under the conditions of the reaction or upon the effect of the components or in a binary, ternary or optionally other mixture of such solvents. As solvent hydrocarbons, such as benzene, toluene, hexane, chlorinated hydrocarbons, such as chloroform, dichloromethane or ethers, such as diethylether, diisopropyl ether or ketones, such as acetone or acetates, such as ethylacetate, or amides, such as dimethylformamide, dimethylacetamide, tetramethylurea, hexamethylphosphortriamide or dioxane or tetrahydrofuran are preferred. if as starting material a free acid is used the reaction is preferably performed in the presence of a water withdrawing agent.As water withdrawing agent symmetric or asymmetric carbodiimide such as dicyclohexyl carbodiimide, diisopropyl carbodiimide is preferred. The reaction of the compounds of the formulae (Il) and (III) is preferably conducted at room temperature.
In the course of process variant b) as halogenating agent phosphorous pentachloride, phosphorous trichloride, phosphoroxychloride, or thionylchloride is preferred. The reaction is carried out under conventional reaction conditions.
The compounds of the general formula (il) are reacted with chloroformic acid esters of the general formula (IV) according to process variant c) at a temperature below 0 C in the presence of an inert solvent. As solvents the same solvents can be used as given in process variant a).
The oxydation of phosphino-carboxylic acids and esters thereof of the general formula (V) is performed with hydrogen peroxide by methods known from the literature Clzv. Akad. Nauk, SSSR, Ser. Him. 290-295 /1962/]. The sulfide derivatives of the general formula (I) can be prepared by the reaction of the corresponding phosphine and sulfur [lzv. Akad. Nauk. SSSR, Ser. Him. 290-295 /1 962/] or by reacting the corresponding oxides of the general formula (Vl) with P4S10 [J. Chem. Research /S/ 232-233 /1978/; /M/ 3041-3063 /1978/].
The preparation of phosphine derivatives of the general formula (I) according to process variants g), h) and i) can be performed by methods known per so [J. Chem. Research /S/, 232-233, /1978/; /M/ 3041-3063/1978/], or[Chem. Ber. 93803/1960/; C.A. 74 18890/1971/].
Further details of our invention are given in the following examples which serve merely for illustration and not for limitation.
Example 1 Diphenyl-phosphino-acetic acid (starting material) (K. Issleib, G. Thomas: Chem. Ber. 93803/1960/] Two equivalents of sodium are dissolved in (70-80cm3/0.1 mole PPh3) liquid ammonia and one equivalent of triphenyl-phosphine is added. The colour of the mixture turns from dark blue into dark brown. One equivalent of ammonium chloride is added very slowly. A white precipitate is formed and an orange smudge is obtained. One equivalent of freshly distilled chloroacetic acid ethyl ester is mixed with ether of the same volume and it is added slowly dropwise. The termination of the reaction is indicated by the pale yellow colour of the mixture. The ammonia is evaporated while the sludge is diluted with ether (40-50cm3/0.1 mole PPh3) the mixture is stirred in order to dissolve the product from the sodium chloride.The salt is filtered off, preferably in nitrogen atmosphere. The hydrolysis of diphenylphosphino acetic acid ethyl ester can be carried out in water and organic solvent as well: a) To the ether solution of the ester (80-90cm3 of ether or petrolether/0. 1 mole ester) a hot concentrated ethanol solution of equivalent amount of potassium hydroxide is poured. Upon cooling the sodium salt of the acid is precipitated, the crystals are filtered and washed with chloroform. Yield: 60%. M.p.: 117-12O"C.
b) The solvent is distilled off from the ether solution of the ester and to the obtained syrup an aqueous solution of equivalent potassium or sodium hydroxide is added and heated in nitrogen atmosphere for a short time. The mixture is treated with charcoal and filtered off. The filtrate is acidified under stirring until the formation of precipitate ceases. The precipitated acid is filtered and washed with cold water. Yield: 90%. M.p.: 120-121"C.
Rf: 0.55 (benzene-ethylacetate-acetic acid = 7:3:1) IR-spectrum: 1 695 cm - 1 acid) (KBr) NMR-spectrum: 8 ppm: 3.04 (s, 2H) (CDCl3) 7.24-7.50 (mml OH) 10.68 (s,1 H) Analysis for the formula C14H,302P (244.215) calculated: C % = 68.90 found: C %2 68.80, 69.06; H % = 5.36 H % = 5.43, 5.49.
Example 2 Diphenyl-carboxymethyl-phosphine-oxide (starting material) 1.22 g. (5 mmole) of diphenyl-phosphino-acetic acid is dissolved in 1 5 ml. glacial acetic acid the solution is heated to 50-55 C and 0.53 g. (33%) H202 is added dropwise under stirring dissolved in 2 ml. of glacial acetic acid. The temperature is maintained under cooling at about 55"C. After a further stirring for 30 minutes the reaction mixture is poured on 200 ml. icy water and extracted with ethyl acetate. After drying the ethylacetate layer is evaporated and the obtained syrup is triturated with absolute ether or n-hexane and crystallized. Yield: 0.98 9.
(74.35 %), m.p.: 138-140"C.
Rf: 0.13 (benzene-ethylacetate-glacial acetic acid = 7:3:1) IR-spectrum: 1730cm-1 Analysis for the formula C,4H,303P (260.21) NMR-spectrum: /DMSO-d6, 100MHz/ ppm: 3.92/s,1H/; 4.O4/s,1H/; 7.8-8.3/m,1OH/ /8/.
Example 3 Diphenyl-carboxymethyl-phosphine-sulfide (starting material) 3.66 g. (15 mmole) of diphenyl-phosphino-acetic acid and 0.53 g. of sulfur powder are heated under reflux in 30 ml. benzene for one hour and the reaction mixture is evaporated in vacuo. If the product is chromatographically homogeneous it can be used for ester formation otherwise it can be crystallized from acetone.
Yield: 3.2 g. (76.55%) Rf: 0.4 (benzene-ethylacetate-glacial acetic acid = 7:3:1).
Mp.: 183-185"C.
IR-spectrum: :1705 cm~/vCO cid) (KBr) Analysis for the formula C14H13O2P'S (276.2-1) calculated: C % = 60.87 found: C % = 60.61, 60.92 H%= 4.70 H%= 4.61 4.87 NMR-spectrum: (DMSO-d6, 100MHz) /8/ppm:4.18 /s,1H/ 4.32 /s,1H/ 7.8-8.4 /m,1OH/ Example 4 Preparation of Diphenyl-phosphino-acetic acid pentachlorophenylester 2.44 g. (10 mmole) diphenyl-phosphino-acetic acid and 2.66 g. (10 mmole) pentachlorophenol are dissolved in 30 ml. dichloromethane and under stirring a solution of 2.06 g. (10 mmole) dicyclohexyl-carbodiimide in 20 ml. dichloromethane is added at room temperature. After stirring for 2 hours the precipitated urea is separated from the reaction mixture by filtration and the mixture is evaporated.The oily syrup type residue is taken up in about 20 ml. of acetone and the white crystalline product is precipitated upon cooling in a refrigerator. Yield: almost quantitative.
M.p.: 110-114"C.
IR-spectrum: 1765 cm-1 (Ycoesi,r) NMR-sepctrum: (CDCI3100MHz, ppm:) 3.40 /s,2H/ /8/ 7.20-7.38 /m,10H/ Analysis for the formula C2cHl2ClsO2P (492.55) Calculated: C % = 48.76 found: C % = 48.66, 49.06; H % = 2.45 H % = 2.85, 2.87; Cl % = 35.99 Cl % = 35.72, 35.86.
Example 5 Preparation of (diphenyl-phosphineoxide)-yl-acetic acid pentachlorophenylester 10 mmole of diphenyl-carboxymethyl-phosphineoxide and 2.66 g. (10 mmole) pentachlorophenol are dissolved in 35 ml. dichloromethane and a solution of 2.06 g. dicyclohexylcarbodiimide in 10 ml dichloromethane is added. The reaction mixture is stirred at room temperature for 3-4 hours whereafter the precipitated urea is filtered and the filtrate is evaporated. The product is triturated with petrol ether. Yield: 4.3 g. (86%).
M.p.: 126-130"C.
Rf: 0.65 (benzene-ethylacetate = 1:1) IR-spectrum: 1780 ('coester) (KBr) Analysis for the formula C20H12Cl5O3P (508.55) Calculated: C % = 47.19 found: C % = 47.79,47.48; H % = 2.35 H % = 2.57, 2.52.
NMR-spectrum: (DMSO-d6, 100MHz) ppm: 3.78 /s,1H/ 3.92 /s,1H/ 7.76-8.2 /m,lOH/ Example 6 Preparation of (diphen yl-phosph ine-suifide)-yl-acetic acid-pentachlorophenylester 10 mmole of diphenyl-carboxymethyl-phosphine-sulfide and 10 mM of pentachlorophenol are dissolved in 40 ml. dichloromethane and a solution of 2.06 g. dicyclohexyl-carbodiimide in 20 ml. of dichloromethane is added. The mixture is stirred for 5 hours at room temperature, filtered and the filtrate is evaporated and crystallized with a mixture of acetone and petrol ether. Yield: 3.2 g. (61%).
M.p.: 168-171"C.
Rf: 0.7 (benzene-ethylacetate = 1:1) IR-spectrum: . 1775 cm-1 (Ycoesier) (KBr) Analysis for the formula C20H12Cl502PS (524.55) Calculated: C % = 45.79 found: C % = 47.06, 47.03; H % = 2.30 H % = 2.40, 2.37.
NMR-spectrum: (DMSO-d6, 100MHz) ppm: 4.20 /s,1H/ 4.36-/s,lH/ 7.8-8.45 /m,lOH/ Example 7 Preparation of (diphenyl-phosphinoxide)-yl-acetic acid N-hydroxy-phthalimide ester 10 mmole of diphenyl-carboxymethyl-phosphineoxide and 10 mmole of N-hydroxy-phthalimide are dissolved in 35 ml. of dichloromethane and 10 mmole dicyclohexylcarbodiimide are added, dissolved in 1 5 ml. of dichloromethane. The reaction mixture is stirred at room temperature for 3-4 hours whereafter the precipitated urea is filtered, the filtrate is evaporated and crystallized from acetone.
Yield: 48%.
M.p.: 149-152"C.
Rf: 0.35 (benzene-ethyl acetate = 1:1) IR-spectrum: 1735 cm-1 (VC0 05ter) (KBr) Analysis for the formula C22H16O5NP (405.24) Calculated: C % = 65.14 found: C % = 64.92, 64.86; H % = 3.94 H % = 3.68 3.72; N % = 3.45 N % = 3.48 3.49.
Example 8 Preparation of diphenyl-phosphino-acetic acid 8-oxyquinoline-ester 1.22 g. of diphenyl-phosphino-acetic acid is dissolved in 25 ml. dichloromethane and the solution of 0.78 g. 8-oxyquinoline in 10 ml. dichloromethane is added at room temperature and to the obtained yellow reaction mixture 1.03 g. dicyclohexyl-carbodiimide is added dissolved in 10 ml. of dichloromethane. The reaction mixture turns white and within a few minutes crystals are precipitated. After stirring at room temperature for 2 hours the precipitated urea is filtered off, the filtrate is evaporated and crystallized with petrolether.
Yield: 0.8 g. (46.92%).
M.p.: 140-143"C.
Rf: 0.65 (benzene-ethyl acetate = 1.1) IR-spectrum: 1705cm1 (KBr) Analysis for the formula C2SH,802NP (372.1 5) calculated: N % = 3.76 found: N % = 3.90, 3.95.
Example 9 Preparation of diphenyl-phosphino-acetic acid-N-hydroxy-succinic imide ester 10 mmole of diphenyl-phophinoacetic acid and 10 mmole of N-hydroxy-succinic imide are dissolved in 40 ml. of dichloromethane and 10 mmole of dicyclohexyl-carbodiimide are added in 20 ml. of dichloromethane and the reaction mixture is stirred at room temperature for 3-4 hours. The precipitated urea is filtered, the filtrate is evaporated and triturated with ether and petrolether whereafter the product is obtained in the form of white crystals. The product is recrystallized from the mixture of acetone and petrolether.
Yield: 64%.
M.p.: 106-108"C.
Rf: 0.73 (benzene-ethyl-acetate = 1:1) IR-spectrum: 1750 cm (KBr) 1785 cm 1810 cm-' Analysis for the formula C18H,8NO4P (341.28) calculated: C % = 63.34 found: C % = 63.96, 64.50; H % = 4.72 H % = 4.92 5.09; N % = 4.10 N % =- 4.20 4.23.

Claims (9)

1. Compounds of the general formula (I)
wherein R3 and R4 are the same or different and can stand for hydrogen, halogen, alkyl, optionally substituted aryl, hydroxy, amino, substituted carbonyl amino, acylamino, mono- or dialkylamino, carboxyl, esterified carboxylic acid or sulphonic acid group or a heteroaromatic group or R3 and R4 together stand for oxo-, hydroxyimino, O-alkylimino or substituted alkylhydroxyimino, R5 stands for phenyl, substituted phenyl, such as trichlorophenyl, pentachlorophenyl, pentafluorophenyl, 1 -methyl-tetrazol-5-yl, 2-methyl-l ,3,4-thiadiazol-5-yl, 1, 3,4-thiadiazol-2-yl, 1,2,3,triazol-4-yl, 1 -substituted-tetrazol-5-yI, pyrrolidin-2, 5-dion- 1 -yl, sacharyl, 1 -phenyl-3-methyl-pyrazol-4-in-5-yl, 8-quinolyl or substituted 8-quinolyl 'or Q4R5 can optionally stand for halogen and R5 can further stand for N,N'-optionally substituted amidine in which the carbon atom of the amidine group is attached to Q4 atom, and R5 can further stand for alkoxycarbonyl, aryloxycarbonyl or aralkyloxycarbonyl, R6 and R7 are the same or different and can stand for hydrogen, straight or branched chained C16 alkyl which can optionally be substituted by one or more nitro groups, halogen atoms, alkoxycarbonyl or dialkylamino groups and R6 and R7 further stand for C36 cycloalkyl, phenyl or a phenyl group optionally substituted by R' or R2 where R1 and R2 are the same or different and can stand for hydrogen, halogen, alkyl, hydroxy, nitro, sulphonic acid, carboxylic or NR9R10 group, wherein R9 and R are the same or different and can stand for C16 alkyl or C37 cycloalkyl or R9 and R'O together with the nitrogen atom can form a C37 heterocyclic ring which can optionally contain other heteratoms or R6 and R7 can optionally be bound to an unsubstituted or substituted atom group forming thus a ring or rings, Qr and Q2 are the same or different and can stand for 0, S or Se or = SH2 group, Q3 can stand for 0, S, Se, = NH, = NR or = N-N = CR12R13, Q4 stands for 0 or S, R", R12 and R'3 stand for C16 alkyl, C37 cycloalkyl, phenyl or substituted phenyl, naphthyl or substituted naphthyl or a cyclic substituent containing one or more hetero atoms which can be substituted or unsubstituted or optionally heteroaromatic, k stands for 0 or 1, m stand for 0 or 1 and n stands for 0 or 1.
2. Process for the preparation of phosphorous containing acetic acid derivatives of the general formula (I)
wherein R3 and R4 are the same or different and can stand for hydrogen, halogen, alkyl, optionally substituted aryl, hydroxy, amino, substituted carbonyl amino, acylamino, mono- or dialkylamino, carboxyl, esterified carboxylic acid or sulphonic acid group or a heteroaromatic group or R3 and R4 together stand for oxo, hydroxyimino, O-alkylimino or substituted alkylhydroxyimino, R5 stands for phenyl, substituted phenyl, such as trichlorophenyl, pentachlorophenyl, pentafluorophenyl, 1 -methyl-tetrzol-5-yl, 2-methyl-1 1,3,4-thiadiazol-5-yl, 1 ,3,4-thiadiazol-2-yl, 1,2,3-triazol-4-yl, 1 -substituted-tetrazol-5-yl, pyrrolidin-2, 5-dion- 1 -yl, sacharyl, 1 -phenyl-3-methyl-pyrazol- 4-in-5-yl, 8-quinolyl or substituted 8-quinolyl or Q4R5 can optionally stand for halogen and R5 can further stand for N,N'-optionally substituted amidine in which the carbon atom of the amidine group is attached to 04 atom, and R5 can further stand for alkoxycarbonyl, aryloxycarbonyl or aralkyloxycarbonyl, R6 and R7 are the same or different and can stand for hydrogen, straight or branched chained C16 alkyl which can optionally be substituted by one or more nitro groups, halogen atoms, alkoxycarbonyl or dialkylamino groups and R6 and R7 further stand for C36 cycloalkyl, phenyl or a phenyl group optionally substituted by R1 or R2 where R' and R2 are the same or different and can stand for hydrogen, halogen, alkyl, hydroxy, nitro, sulphonic acid, carboxylic or NR9R'0 group, wherein R9 and R10 are the same or different and can stand for C16 alkyl or C37 cycloalkyl or R9 and R10 together with the nitrogen atom can form a C37 heterocyclic ring which can optionally contain other heteroatoms or R6 and R7 can optionally be bound to an unsubstituted or substituted atom group forming thus a ring or rings, Q' and 02 are the same or different and can stand for 0, S or Se or = CH2 group, Q3 can stand for 0, S, Se, = NH, = NR" or = N-N = CR'2R'3, Q4 stands for 0, or S, R", R12 and R'3 stand for C18 alkyl, C37 cycloalkyl, phenyl or substituted phenyl, naphthyl or substituted naphthyl or a cyclic substituent containing one or more hetero atoms which can be substituted or unsubstituted or optionally heteroaromatic, k stands for 0 or 1, m stands for 0 or 1 and n stands for 0 or 1--- which comprises a) reacting a compound of the general formula (II)
wherein R3, R4, R6, R7, 01, Q2, (13, n, m and k are as given above and R stands for hydrogen, metal atom, C18 alkyl or C36 cycloalkyl-with a compound of the general formula (III) H(14R5, (III) wherein Q4 stands for 0 or S, R5 stands for phenyl, substituted phenyl such as trichlorophenyl, pentachlorophenyl, pentafluorophenyl, 1 -methyl-tetrazol-5-yl, 2-methyl- 1 , 3,4-thiadiazol-5-yl, 1, 3,4-thiadiazol-2-yl, 1,2,3-triazol-4-yl, 1 -su bstituted-tetrazol-5-yl, pyrrolidin-2, 5-dion- 1 -yl, sacharyl, 1 -phenyl-3-methyl-pyrazol- 4-in-5-yl, 8-quinolyl or substituted 8-quinolyl group or N,N1-optionally substituted amidine-wherein the carbon atom of the amidine group is attached to Q4 atomor b) reacting the compound of the general formula (II) wherein the substituents are as given-above--with a halogenating agent in order to prepare ompound of the general formula (I) containing halogen in place of Q4R5 or c) reacting a compound of the general formula (II) wherein the substituents are as given above with the compound of the general formula (IV) X-COOR'4 (IV) wherein X stands for halogen and R14 stands for alkoxycarbonyl, aryloxycarbonyl or aralkyloxycarbonyl-in order to prepare a compound of the general formula (I) which contains alkoxycarbonyl, aryloxycarbonyl or aralkoxycarbonyl in place of R5, or d) oxidizing a compound of the general formula (V)
wherein R3, R4, R5, Re, R7 and Q4 are as given above--in order to prepare a compound of the general formula (I)--wherein k and n stands for 0, m stands for 1, Q represents oxygen and R3, R4, R5, R6, R7 and Q4 are as given above--or e) reacting a compound of the general formula (V) with sulfur in order to prepare a compound of the general formula (I)--wherein k and m stand for 0, n stand for 1, Q3 is sulfur and R3, R4, R5, Re, R7 and Q4 are as defined above--, or f) reacting a compound of the general formula (VI)
wherein R3, R4, R5, R, R7 and Q4 are as defined above--with P4SXo in order to prepare a compound of the general formula (I)--wherein k and m stand for 0, n stands for 1, Q3 is sulfur and R3, R4, R5, R6, R7 and Q4 are as defined above or g) reducing a compound of the general formula (VlWwherein R3, R4, R5, R6, R7 and Q4 are as defined above--selectively with phenyl silane, in order to prepare a compound of the general formula (I)--wherein k, m and n stand for 0, R3, R4, R5, R6, R7 and Q4 are as given above--or h) desulfurating a compound of the general formula (Vll)
wherein R3, R4, R5, R6, R7 and Q4 are as given above, in order to prepare a compound of the general formula (I)--wherein k, m and n stand for 0, R3, R4, R5, R6, R7 and Q4 are as given above, or i) reacting a compound of the general formula (VIII) ReR7PM (VIII) --wherein R6 and R7 are as given above and M stands for hydrogen or a metal 'atom-with a compound of the general formula (IX)
wherein Hlg stands for halogen, s stands for 0 or 1 and R3, R4, R5 and Q4 are as given above--, in order to prepare a compound of the general formula (I)wherein m, k and n stand for 0, R3, R4, R5, Re, R7 and Q4 are as given above--.
3. Process according to process variant a) in claim 2 which comprises carrying out the reaction of the compounds of the general formulae (II) and (III) in an inert solvent or in a mixture of such solvents optionally in the presence of water withdrawing agent at room temperature.
4. Process as claimed in claim 3 which comprises using as water withdrawing agent a symmetric or asymmetric carbodiimide.
5. Process according to process variant c) in claim 2 which comprises conducting the reaction in an inert solvent or in a mixture of inert solvent at a temperature below 0 C.
6. Process according to variants a) and c) in claim 2 and according to claims 3 and 5) which comprises using as a solvent chlorinated hydrocarbons, ethers, dipolar-aprotic solvents.
7. Pharmaceutical compositions comprising as active ingredient a compound of the general formula (I) as claimed in claim 1.
8. A compound as claimed in claim 1, said compound being the title product of any of the Examples herein.
9. A compound of formula X or formula Xl herein when prepared from a compound as claimed in claim 1.
GB08412637A 1983-05-17 1984-05-17 Phosphorus substituted acetic acid derivatives Withdrawn GB2141123A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU171583A HU190449B (en) 1983-05-17 1983-05-17 Process for production of derivatives of acetid acid substituated by phosphorus

Publications (2)

Publication Number Publication Date
GB8412637D0 GB8412637D0 (en) 1984-06-20
GB2141123A true GB2141123A (en) 1984-12-12

Family

ID=10955824

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08412637A Withdrawn GB2141123A (en) 1983-05-17 1984-05-17 Phosphorus substituted acetic acid derivatives

Country Status (4)

Country Link
JP (1) JPS6056990A (en)
FR (1) FR2547584A1 (en)
GB (1) GB2141123A (en)
HU (1) HU190449B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698874A1 (en) * 1992-12-07 1994-06-10 Commissariat Energie Atomique Process for the preparation of acetoamide derivatives, acetothioamides and acetoselenoamides, in particular carbamoylmethylphosphine and carbamoylmethylphosphine derivatives thus obtained.
WO1997018714A1 (en) * 1995-11-22 1997-05-29 The Minister Of Agriculture Fisheries & Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Alkylphosphines as pesticidal agents
GB2322553A (en) * 1995-11-22 1998-09-02 Mini Agriculture & Fisheries Alkylphosphines as pesticidal agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB823415A (en) * 1955-09-12 1959-11-11 Ciba Ltd Preparations containing phosphorus- and halogen-containing condensation products
GB1544541A (en) * 1976-04-30 1979-04-19 Abbott Lab Phosphorus esters of phosphonoacetic acid
GB1553344A (en) * 1976-04-30 1979-09-26 Abbott Lab Carboxylic esters of phosphonoacetic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH631182A5 (en) * 1977-08-30 1982-07-30 Kz Khim Tekh Inst Kirova Process for preparing the hydrazide of diphenylphosphinylacetic acid.
JPS58135895A (en) * 1982-02-05 1983-08-12 Mitsui Toatsu Chem Inc Nucleoside phosphorylating reagent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB823415A (en) * 1955-09-12 1959-11-11 Ciba Ltd Preparations containing phosphorus- and halogen-containing condensation products
GB1544541A (en) * 1976-04-30 1979-04-19 Abbott Lab Phosphorus esters of phosphonoacetic acid
GB1553344A (en) * 1976-04-30 1979-09-26 Abbott Lab Carboxylic esters of phosphonoacetic acid

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698874A1 (en) * 1992-12-07 1994-06-10 Commissariat Energie Atomique Process for the preparation of acetoamide derivatives, acetothioamides and acetoselenoamides, in particular carbamoylmethylphosphine and carbamoylmethylphosphine derivatives thus obtained.
WO1994013683A1 (en) * 1992-12-07 1994-06-23 Commissariat A L'energie Atomique Method for preparing acetoamide, acetothioamide and acetoselenoamide derivatives
WO1997018714A1 (en) * 1995-11-22 1997-05-29 The Minister Of Agriculture Fisheries & Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Alkylphosphines as pesticidal agents
GB2322553A (en) * 1995-11-22 1998-09-02 Mini Agriculture & Fisheries Alkylphosphines as pesticidal agents
AU708044B2 (en) * 1995-11-22 1999-07-29 Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland, The Alkylphosphines as pesticidal agents
GB2322553B (en) * 1995-11-22 2000-01-19 Mini Agriculture & Fisheries Pesticidal use of aliphatic phosphines
US6096330A (en) * 1995-11-22 2000-08-01 The Secretary Of State For Minister Of Agriculture Fisheries & Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Alkylphosphines as pesticidal agents

Also Published As

Publication number Publication date
JPS6056990A (en) 1985-04-02
HUT34512A (en) 1985-03-28
FR2547584A1 (en) 1984-12-21
GB8412637D0 (en) 1984-06-20
HU190449B (en) 1986-09-29

Similar Documents

Publication Publication Date Title
SU451244A3 (en) The method of obtaining derivatives of phenylimidazolyl
IE47467B1 (en) Imidazoline derivatives and their salts
GB2141123A (en) Phosphorus substituted acetic acid derivatives
DE2205745A1 (en) N-cyanoimino substd heterocyclic cpds - inters for eg antidiabetics and diuretics
DE2614189A1 (en) Analgesic, antiinflammatory and antipyretic thiazolyl-urea derivs. - prepd. by reacting an isocyanato-carboxylic acid cpd. with an amino-or hydrazino-thiazole
US4303664A (en) Novel penicillin derivatives containing a coumarin nucleus and medicines containing the same
US4145418A (en) Thienopyridine substituted cephalosporins
EP0078804A1 (en) Method of preparation of delta2 n-heterocycles
FR2496666A1 (en) NOVEL CEPHALOSPORINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
DE2804040C3 (en) Process for the preparation of cephem compounds
EP0040332B1 (en) Antihypertensive lactams
US3798229A (en) Process for preparing 1,3,4-thiadiazole-2-thiol compounds
EP0500952B1 (en) Process for producing nitrogenous heterocycle
Sabri et al. Synthesis and spectral properties of some N‐(2‐benzimidazoyl)‐α‐aminoesters and their N‐oxides
Lo et al. 5-Alkoxymethylenerhodanines and their Reactions with Rhodanines1
DE3418088A1 (en) Phosphorus-containing acetic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
SU453842A3 (en)
FI69838B (en) REFERENCE TO A FRAMSTAELLNING AV 1,2,3-THIADIAZOLE-5-YLURINAEMNEN
EP0287853B1 (en) A process for the preparation of 1-alkyl-3-carboxy-4-cinnolones.
CA1338710C (en) Process for preparing intermediates
Stachel et al. Metal Complexes of Functionalized Sulfur‐Containing Ligands. Part XIX: Synthesis and Reactions of New Pyrroloisothiazoles
US4003887A (en) Novel penicillins and their preparation
US3225058A (en) Substituted n-(4-pyrimidinyl)-6-aminopenicillanic acids
US4130559A (en) Method for the preparation of 6-aminopenicillinic acid derivatives
JP2525013B2 (en) Novel crystalline cephalosporin derivative

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)